Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAPROXEN vs NATALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAPROXEN vs NATALIZUMAB: Safety Overview

Metric NAPROXEN NATALIZUMAB
Total FAERS Reports 52,751 64,315
Deaths Reported 5,127 3,140
Death Rate 9.7% 4.9%
Hospitalizations 12,849 17,879
Average Patient Age 55.0 yrs 45.6 yrs
% Female Patients 71.5% 78.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Aurobindo Pharma Limited Sandoz Inc
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription